Lv11
40 积分 2026-01-30 加入
Targeting CDK2 and other novel cell cycle targets for breast cancer therapy
15天前
已完结
Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
15天前
已完结
Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer
22天前
已完结
Development of selective mono or dual PROTAC degrader probe of CDK isoforms
1个月前
已完结
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
1个月前
已完结
AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss
1个月前
已完结
Selective CDK2 Degradation via Noncanonical Recruitment
1个月前
已完结
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
1个月前
已完结
Molecular markers and venous thromboembolism (VTE) in acute myelogenous leukemia (AML)
1个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
6个月前
已完结